Objective: This study examines the relative impact of antidepressant side effects on adolescents with a history of major depression.
M ajor depressive disorder (MDD) in adolescents is recognized as a serious psychiatric illness with extensive acute and chronic morbidity and mortality. The period prevalence rate is estimated to reach 6% to 8% and is characterized by a recurrence rate of 60% to 80% by the end of adolescence (1) . Antidepressant medications have become an important component in managing adolescent depression. Double-blind trials of tricyclic antidepressants have failed to show any greater efficacy than placebo, and concerns have been raised about the risks of using these treatments in adolescents, who appear to be particularly sensitive to the side effects of these medications (2, 3) .
Newer antidepressants, such as the selective serotonin reuptake inhibitors (SSRIs), have a lower side effect burden and may potentially be better tolerated in the adolescent population, and therefore more effective, than the older medications (4) . Several double-blind, placebo-controlled trials have studied the efficacy of SSRIs in adolescent depression (5) (6) (7) . The largest study involved 275 patients and demonstrated significantly higher remission rates for subjects in the paroxetine group, compared with imipramine or placebo (7) .
Much of the research in child and adolescent depression has focused on the effectiveness and efficacy of antidepressants (8) . Less attention has been paid to side effects and their impact on compliance and quality of life for these patients. To date, no study has specifically examined these issues in this age group. Therefore, we studied the impact of adverse effects from antidepressants on quality of life to better inform clinicians and researchers on the consequences of prescribing antidepressant treatments and to potentially aid in the development of new antidepressants.
Our current understanding of the impact of potential antidepressant side effects on adolescents with depression is limited to studies that only examine the frequency and severity of adverse effects. Several studies using SSRIs have reported the frequency of side effects in adolescent patients (7, 9, 10) . However, reporting the frequency of occurrence alone does not truely represent the impact of side effects, as was clearly illustrated by Boulos and others, who evaluated side effects in 15 adolescents and young adults with depression treated with fluoxetine (9) . The most common side effects were dry mouth, nausea, sweating, tremor, and decreased appetite. However, the most severe side effects were not the most frequent. For example, restlessness occurred in only 27% of the subjects, but all subjects ranked it as severe, compared with tremor. The latter side effect occurred in 40% of the subjects but was ranked severe by only 1 out of 6 subjects. These data illustrate the importance of measuring the impact, rather than just the frequency, of side effects.
Understanding the impact of side effects is further complicated by the role that age and history of depression may play in altering a person's subjective experience. For example, if a side effect resembles a symptom of depression, patients with a history of depression may report greater impact. There are no data comparing assessments of the impact of side effects made by adolescent patients suffering from depression with assessments from healthy adolescents or from adults who also have a history of depression. Finally, although clinicians who treat adolescents with depression regularly assess the impact of side effects, it is not known whether physician impressions of the impact of side effects are similar to adolescent perceptions. Therefore, this study evaluates the subjective experience of antidepressant side effects in adolescents with a history of depression and compares it with the perceptions of healthy adolescents and of adults with a history of depression, and also with the judgement of the clinicians treating adolescent patients.
Methods

Q-sort Methodology
Although patients commonly experience medication side effects, not all will experience all the most common side effects. Therefore, to examine the most common side effects and their impact on quality of life, subjects must evaluate side effects that they may or may not have experienced in the past. In other words, subjects must be asked for their opinion on the impact of all possible side effects. Consequently, the methodology used must be capable of measuring individuals' opinions. Q-sort methodology contrasts with the more traditional methods of evaluating subjectivity, such as the Likert scale (11) . In Q-sort methodology, patients are asked to consider all items in relation to each other. Q-sort methodology allows for both the measurement of opinion and for judging the relative impact of various factors (12) . Given these advantages, we chose Q-sort methodology for this study.
Producing the Q-sort
We compiled a list of all SSRI side effects from 3 SSRI trials in adolescents. We also added 3 additional SSRI side effects deemed to be most common from adult studies, for a total of 40 side effects. Each side effect was listed on an individual card, called a Q-card. Each side effect was described in terminology easily understood by adolescents (for example, vertigo = "feeling like the room is spinning").
The number of Q-cards was limited to 40, because with 40 Q-cards force ranked into 7 slots, the Q-sort best simulated a normal distribution. One author developed the model for the Q-sort: each Q-card is force ranked into 1 of 7 slots with semantic tags that explain the ranking. On one end is the side effect with the most impact (1 card), labelled as "-3"; on the other is the side effect with the least impact (1 card), labelled as "+3." Side effects with neutral impact (labelled as "0") are placed in the centre slot. The number of cards placed in each slot is designed to best approximate a quasi-normal distribution.
Subjects
We recruited adolescent subjects with a history of depression through advertisements at 2 tertiary care centres and through radio advertisement. We recruited adult subjects with a history of depression at a tertiary care centre. We recruited adolescent psychiatrists from the Canadian Academy of Child Psychiatry listing and interviewed them based on their availability. Clinicians were eligible if they reported that more than 50% of their clinical practice involved adolescents with mood disorders. We recruited healthy adolescent subjects through local high schools. Table 1 lists the inclusion and exclusion criteria for the patient groups.
Procedures
Except for clinician subjects, all subjects were screened for current symptoms of depression according to the Hamilton Depression Rating Scale (HDRS) (13) and the Structured Clinical Interview for DSM-IV (SCID-IV) (14) . We excluded any subjects that met criteria for a current episode of major depression. Adolescent subjects had to have at least a Grade 7 reading level.
Once subjects were identified and found eligible for the study, the research coordinator obtained informed consent. At the initial appointment, each subject (excluding clinician subjects) completed a demographics questionnaire, the Slosson Oral Reading Test (SORT) (15), the SCID-IV, and the HDRS. Subjects were then asked to complete the Q-sort. Initially, they were asked to review all 40 Q-cards and divide them into 3 piles: those with most impact, those with least impact, and those in the neutral category. The subjects were then asked to choose Q-cards for each slot, alternating between the negative and positive slots. Each subject was asked to start by choosing the Q-card with the most impact followed by the Q-card with the least impact. They then repeated the exercise, selecting the next 4 Q-cards with the most impact. This procedure continued until 12 cards remained from the original 40 cards, which were placed in the neutral (centre) slot.
After completing the Q-sort, the subjects completed the Scale for Medication Compliance (SMC) and the Visual Analogue Scale for Side Effect-Related Health Status (VAS Health Status). The SMC was developed for this study to measure the level of compliance for any given side effect. Subjects were asked to rate their level of compliance if they were to experience daily the side effect that they rated as having the most impact on their lives. The scale used a 10-cm line with points marked 0%, 10%, 20%, and so on, up to 100%. Subjects could mark any place on the line. Their response mark was measured according to the distance from 0%; that is, if the response was at 23 mm from 0%, the score was recorded as 23%. The VAS Health Status scale was also developed for this study to evaluate how subjects viewed their health status if given a hypothetical side effect. Subjects were asked to rate how they would describe their life if they were to experience daily the side effect they ranked as having the most impact, the least impact, or a neutral impact. The scale used a 9-cm line similar to the SMC, with 10 points marked from 1 ("near death") to 10 ("perfect health"); subjects were asked to choose a point that reflected their side effect-related health status. Because in this case the left anchor point was set at 1 ("near death"), a response at 23 mm from the left anchor was recorded as 3.3.
Statistical Analyses
For the primary analyses, we compared the mean rankings for each side effect using t-tests. We conducted planned paired comparisons of the mean rankings for the adolescents with depression and for each of the other 3 subject groups. We chose to conduct multiple planned paired comparisons instead of analysis of variance because the relevant comparisons were between the adolescents with depression and the other groups and not overall comparison of all 4 groups. Given the number of statistical tests completed for the primary analyses, we used For the secondary analyses, we used the t-statistic to compare the mean ratings for compliance and side effect-related health status. Finally, we used Fisher's exact test to evaluate the differences in the reasons given by each group for choosing the side effect with the most impact.
Results
Subjects
In total, we evaluated 82 subjects: 18 clinicians, 22 adolescents with depression, 22 healthy adolescents, and 20 adults with depression. At screening, 2 healthy subjects met criteria for a past episode of depression and were excluded. The mean ages for the adolescents with depression and the healthy adolescents were 17.1 years (range 14 to 19 years) and 16.7 years (range of 13 to 19 years), respectively. In each of the patient groups, the sex ratio was skewed toward female subjects: 78% of the adolescents with depression, 76% of the adults with depression, and 75% of the healthy adolescents were female. The mean HDRS score of the adolescents with depression (mean 5.3, SD 3.5) was significantly greater than the mean score for the healthy adolescents (mean 1.88, SD 2.19; t = 3.46, df 39, P < 0.02). The mean HDRS score for adults with depression (mean 4.4, SD 4.17, t = 0.78, df 39, P = 0.44) did not differ significantly from that for the adolescents with depression.
Ranking of Side Effects
For the side effect anxiety, the mean rankings by clinicians and healthy adolescents differed significantly from the mean ranking by the adolescents with depression. Clinicians (mean 0.67, SD 1.09; t = 3.71, df 40, P = 0.001) and healthy adolescents (mean 0.45, SD 0.83; t = 3.58, df 40, P = 0.001) both rated anxiety as having less impact, whereas adolescents with depression rated anxiety as having more impact (mean -0.59, SD 1.05). Adults with depression rated the side effect hair loss as having significantly less impact (mean 0.70, SD 1.30), compared with the adolescents with depression (mean -1.05, SD 1.33; t = 4.30, df 40, P < 0.001). Finally, adults with depression rated the side effect sleepiness as more negative (mean -0.25, SD 0.97), whereas adolescents with depression rated it as more positive (mean 0.82, SD -1.01; t = 3.50, df 40, P = 0.001)
The mean rankings for the top 5 side effects were numerically similar across all groups, with the only statistically significant differences listed above. We also compared the mean scores of the adolescents with depression and the other groups for any side effect that had a numerical difference greater than 1. This numerical difference would represent a mean difference of 1 category or greater in the Q-sort. Sexual dysfunction was the only side effect, other than anxiety, sleepiness, and hair loss, that had a numerical difference greater than 1 in mean scores. This numerical difference was found between adolescents with depression (mean 0.14, SD 1.36) and clinicians (mean -1.11, SD 0.96; t = 3.28, df 38, P = 0.002). Table 2 lists the 5 side effects ranked as having the most impact by each of the groups. All 4 subject groups ranked syncope and vomiting as 1 of the 5 side effects with the most impact. Adolescents with depression ranked vomiting, syncope, confusion, hair loss, and anxiety as having the most impact.
Compliance With Medications
We asked adolescents with depression, healthy adolescents, and adults with depression to use the SMC to rate their level of compliance. We asked clinicians to rate the level of compliance that they would expect from their adolescent patients. The mean levels of compliance rated by adolescents with depression (mean 21.36, SD 23.26), compared with healthy adolescents (mean 22.5, SD 24.90; t = 1.10, df 36, P = 0.28), adults with a history of depression (mean 39.5, SD 45.62; t = 1.82, df 39, P = 0.08), and clinicians judging the compliance rate of their adolescent patients (mean 11, SD 15.89; t = 1.54, df 38, P = 0.13) did not differ significantly.
Judgement of Health Status
We also asked subjects to rate their perceived side effect-related health status, according to the VAS Health Status, for the side effect with the most impact, the side effect with the least impact, and a side effect with a neutral impact. Table 3 shows the mean ratings for each subject group. Planned comparisons between adolescents with depression and the other groups did not show any significant differences in mean VAS Health Status score for the side effect rated as neutral and the side effect rated as having the most impact. However, with regard to the side effect with least impact, the mean ratings for side effect-related health status by clinicians (mean 7.2, SD 2.44) and by adolescents with depression (mean 8.7, SD 1.10; t = 2.43, df 38, P = 0.013) differed significantly.
Reasons for Rating a Side Effect as Having the Most Impact
We presented subjects with the side effect they rated as having the most impact and asked them to give reasons for their selection. These reasons were grouped into the following different categories: medical concerns, impaired functioning, emotional distress, and miscellaneous.
Paired comparisons showed significant differences between the proportion of adolescents with depression (14%) and healthy adolescents (56%, Fisher's exact P = 0.03) who gave "medical concerns" as the reason for rating a side effect as having the most impact on their daily lives (Table 4) .
Discussion
In this study, we found both similarities and differences between adolescents with depression and the other 3 groups in the profile of opinions regarding the impact of side effects. The mean rankings for 2 side effects-vomiting and syncope-were homogeneous: all 4 groups ranked these as 1 of the 5 side effects with the most impact. Given this similarity across all groups, health professionals need to address these 2 side effects when prescribing medications, and researchers need to consider their impact when developing new drugs.
However, the mean ratings of side effects that adolescents ranked as having the most impact on their lives also showed significant differences, especially in regard to hair loss and anxiety. Hair loss had less negative impact on adults with depression, compared with adolescents with depression. This result may represent less concern on the part of adults regarding their physical appearance. Adolescents with depression rated anxiety as having more impact, compared with clinicians and healthy adolescents. One explanation for this finding is that the group with a history of depression has experienced anxiety as part of their illness. Therefore, this side effect may signify to them the onset of a new episode of depression. In contrast, clinicians may view anxiety as an easily managed side effect of a medication, and healthy adolescents may view anxiety as the feeling they might experience when writing an exam or giving an oral report.
Of interest is the difference in clinicians' ability to judge the impact of sexual side effects. Clinicians in this study rated Healthy adolescents (n = 16) a Using Fisher's exact test for each group compared with adolescents with depression for each reason given, the proportion of healthy adolescents who selected medical concerns differed from the adolescents with depression (P > 0.05).
sexual dysfunction as having more impact than did adolescents with depression. In fact, for adolescents with depression, the mean ranking for sexual dysfunction was in the positive range, whereas for clinicians, it was in the negative range. Adolescents may not see this side effect as having significant impact because they are not sexually active, or perhaps the impact of this side effect in this population is not as important as clinicians may anticipate. Alternatively, clinicians may base their opinion on real-world experience, whereas adolescents with depression are asked a hypothetical question.
Compared with adolescents with depression, healthy adolescents were more likely to give medical concerns as the reason for ranking a side effect as having the most impact on their daily lives. Adolescents with depression were more concerned with functional impairments from side effects. One possible explanation for this observation may be that healthy adolescents have experienced few psychiatric symptoms and are generally healthier. Healthy adolescents may be less aware of, and therefore less concerned about, the impact of functional impairments from both physical and emotional perspectives.
Compared with adolescents with depression, adults more frequently listed functional impairment as the reason for ranking a side effect as having the most impact. This may represent the more severe consequences for adults of impaired ability to function in daily life, compared with adolescents. For example, if adult patients have difficulties functioning in their jobs, this will likely lead to significant financial difficulties. In contrast, adolescents with similar impairments at school will still be supported by their parents or guardians. Clinicians' reasons for rating a side effect as having the most impact were divided between medical concerns and functional impairment. Ideally, this may represent the clinicians' need to understand the impact of side effects on all aspects of patient well-being, both functional and medical.
Q-sort methodology is used to measure and compare opinions among groups. It was developed to measure subjectivity and yet allow researchers to use more traditional statistical methods in their analyses. Because it is a measure of subjectivity, there are no built-in validators for data collected with this methodology. For example, subjects are limited by the force rank, and therefore, when a side effect is rated as negative, it may simply represent the limitations of the force rank rather than a true negatively valued opinion. However, when we examined the mean VAS Health Status ratings for all subjects, we found significant differences in the mean ratings for the side effect ranked as having the most impact, the least impact, and a neutral impact. This finding likely represents a meaningful variability in the perceived impact of the side effects ranked in the 3 categories. Further confirming this interpretation is the observation that the total mean rating for VAS Health Status for the side effect ranked as having the most impact was similar to the health status ratings from other research examining the impact of severe depression (16) . In a study by Schaffer and others, the mean health utility score of subjects with severe depression was 0.31 (with 0 being "near death" and 1 being "perfect health"). This finding is very similar to the mean health status score for the side effect ranked as having the most impact (mean 3.2) from this study. Therefore, the impact of side effects could have as much impact on patients' daily lives as severe depression itself.
Finally, compliance with medications is a major problem in clinical practice. The differences in mean ratings for compliance in the 3 planned comparisons did not reach statistical significance, but there were numerical differences. Clinicians judged the compliance rates of adolescent patients to be lower than the rates reported by the adolescents themselves. There are several possible explanations for these differences: 1) clinicians may misjudge their patients' level of tolerance for side effects; 2) not wanting to be perceived as "bad" patients, adolescents may give an inflated rate of compliance owing to social desirability; and 3) the question was hypothetical and therefore may not be translated into the real world.
This study has several limitations. First, the sample was small (n = 82). However, the standard number per subject group for Q-methodology has been approximately 20 per group (11) . Second, we asked clinicians to give general information on adolescent patients rather than information on a specific individual under their care. In other words, we did not study clinician-patient pairs, a direct evaluation that might have provided a more comprehensive indication of the agreement between clinicians and their patients with regard to the impact of side effects. Finally, Q-sort methodology involves hypothetical situations. It is possible that adolescents might rank the impact of side effects differently if they were experiencing them at the time of ranking. Notwithstanding this concern, there are no other methods to evaluate the impact of side effects that patients may not have experienced. The current Q-sort is a reasonable approach to quantifying subjectivity in the context of a potentially hypothetical situation.
This study examined the impact of side effects on adolescents with depression, compared with adults with depression, healthy adolescents, and the judgement of clinicians. We found both similarities and differences in the groups. Further research in this area might address the reliability of clinicians' judgement for specific patients and the reliability of parents' judgement regarding the impact of side effects (given that parents frequently act as medical informants for their adolescent children). Researchers might also consider directly measuring the impact (and not just frequency) of side effects in clinical trials of antidepressants in adolescents with depression.
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Résumé : Les répercussions des effets secondaires des antidépresseurs sur la qualité de vie des adolescents
Objectif : Cette étude examine les répercussions relatives des effets secondaires des antidépresseurs sur les adolescents ayant des antécédents de dépression majeure.
Méthodes : Nous avons utilisé la méthodologie Q-sort pour recueillir les opinions d'adolescents ayant des antécédents de dépression (n = 22), d'adultes ayant des antécédents de dépression (n = 20), d'adolescents en santé (n = 20), et de cliniciens (n = 18) sur les répercussions des effets secondaires de 40 antidépresseurs communs. Nous avons demandé aux sujets de classer les effets secondaires selon leur force, en jugeant les répercussions relatives de chaque effet secondaire sur leur vie quotidienne. Nous avons aussi examiné les répercussions de ces effets secondaires sur l'état de santé et l'observance des médicaments. Les analyses primaires comparaient les classements moyens des effets secondaires de chacun des 40 antidépresseurs effectués par les adolescents souffrant de dépression avec ceux des autres groupes. Les analyses secondaires comprenaient des comparaisons par paires des classements de l'état de santé et de l'observance.
Résultats :
Bien que tous les groupes aient classé la syncope et les vomissements parmi les 5 pires effets secondaires, des différences significatives ont été repérées entre les groupes au sujet des autres effets secondaires, comme l'anxiété, la somnolence et la perte de cheveux. En fonction de l'effet secondaire ayant les répercussions les plus négatives, les adolescents souffrant de dépression jugeaient que leur propre observance (moyenne = 22 %) était supérieure à la prédiction des cliniciens (moyenne = 11 %). Il n'y avait pas de différences significatives entre les groupes en ce qui concerne le classement moyen de l'état de santé.
Conclusions :
Il y avait unanimité entre les adolescents souffrant de dépression et les adultes souffrant de dépression, les adolescents en santé et les cliniciens sur les répercussions négatives de 2 effets secondaires : les vomissements et la syncope. La méthodologie Q-sort donne une bonne idée des similitudes et des différences d'opinions en ce qui a trait aux répercussions éventuelles des effets secondaires chez les groupes de patients.
